
### [NCIT:C3758](http://purl.obolibrary.org/obo/NCIT_C3758)
**Label:** Hepatocellular Adenoma

**Subclasses:** [NCIT:C96760](http://purl.obolibrary.org/obo/NCIT_C96760) (Inflammatory Hepatocellular Adenoma), [NCIT:C96761](http://purl.obolibrary.org/obo/NCIT_C96761) (Unclassified Hepatocellular Adenoma), [NCIT:C96759](http://purl.obolibrary.org/obo/NCIT_C96759) (Beta-Catenin-Activated Hepatocellular Adenoma), 

**Class expressions from DL-Learner:**

- Thing 53.30%
- [UBERON:0006925](http://purl.obolibrary.org/obo/UBERON_0006925) (digestive system gland) 52.94%
- [UBERON:0002423](http://purl.obolibrary.org/obo/UBERON_0002423) (hepatobiliary system) 52.94%
- [UBERON:0002107](http://purl.obolibrary.org/obo/UBERON_0002107) (liver) 52.94%
- [UBERON:0001280](http://purl.obolibrary.org/obo/UBERON_0001280) (liver parenchyma) 52.94%
- [NCIT:C41457](http://purl.obolibrary.org/obo/NCIT_C41457) (Well-Circumscribed Lesion) 52.94%
- [NCIT:C36156](http://purl.obolibrary.org/obo/NCIT_C36156) (Favorable Clinical Outcome) 52.94%
- [NCIT:C35380](http://purl.obolibrary.org/obo/NCIT_C35380) (Hemorrhagic Change) 52.94%
- [CL:0000417](http://purl.obolibrary.org/obo/CL_0000417) (endopolyploid cell) 52.94%
- [CL:0000412](http://purl.obolibrary.org/obo/CL_0000412) (polyploid cell) 52.94%
- [CL:0000182](http://purl.obolibrary.org/obo/CL_0000182) (hepatocyte) 52.94%
- [CL:0000181](http://purl.obolibrary.org/obo/CL_0000181) (metabolising cell) 52.94%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 38.30%
- [UBERON:0000353](http://purl.obolibrary.org/obo/UBERON_0000353) (parenchyma) and [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) 38.30%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([CL:1000681](http://purl.obolibrary.org/obo/CL_1000681) (kidney cortex interstitial cell))) 38.30%


